Key factors that determine the selection of first-line ALK inhibtiors

Date 11 April 2018
Event ELCC 2018 European Lung Cancer Congress
Session First line for oncogene addicted lung cancer
Topics Non-Small-Cell Lung Cancer, Locally Advanced
Cancer Immunology and Immunotherapy
Lung and other Thoracic Tumours
Presenter Fiona Blackhall
Authors F.H. Blackhall
  • -, The Christie NHS Foundation Trust, M20 4BX - Manchester/GB